Literature DB >> 10624798

Effect of insulin-like growth factor-I on growth hormone-releasing factor receptor expression in primary rat anterior pituitary cell culture.

H Sugihara1, N Emoto, H Tamura, J Kamegai, T Shibasaki, S Minami, I Wakabayashi.   

Abstract

We examined the effect of insulin-like growth factor-I (IGF-I) on GH-releasing factor (GRF) receptor expression in the primary rat anterior pituitary cell culture. The levels of GRF receptor mRNA were dose-dependently reduced by IGF-I treatment for 24 h. To clarify whether altered levels of GRF receptor mRNA contribute to GRF receptor concentrations, we examined the GH response to GRF in vitro. There was no difference in basal GH secretion between control and IGF-I pretreated cells, while GRF-stimulated GH secretion in cells pretreated with IGF-I for 24 h was significantly lower than that in control cells. Moreover, specific [125I] Tyr10-human GRF binding to pituitary cells was reduced significantly by IGF-I treatment. These results suggest that IGF-I acts directly on the pituitary and participates in the regulation of GRF receptor expression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10624798     DOI: 10.1016/s0304-3940(99)00801-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  7 in total

1.  PI3K/Akt/mTOR pathway involvement in regulating growth hormone secretion in a rat pituitary adenoma cell line.

Authors:  Carmelina Di Pasquale; Erica Gentilin; Simona Falletta; Mariaenrica Bellio; Mattia Buratto; Ettore Degli Uberti; Maria Chiara Zatelli
Journal:  Endocrine       Date:  2017-10-27       Impact factor: 3.633

Review 2.  A model for tissue-specific inducible insulin-like growth factor-I (IGF-I) inactivation to determine the physiological role of liver-derived IGF-I.

Authors:  Klara Sjögren; John-Olov Jansson; Olle G P Isaksson; Claes Ohlsson
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

3.  Targeted deletion of somatotroph insulin-like growth factor-I signaling in a cell-specific knockout mouse model.

Authors:  Christopher J Romero; Yewade Ng; Raul M Luque; Rhonda D Kineman; Linda Koch; Jens C Bruning; Sally Radovick
Journal:  Mol Endocrinol       Date:  2010-03-08

4.  Insulin-like growth factor 1 mediates negative feedback to somatotroph GH expression via POU1F1/CREB binding protein interactions.

Authors:  Christopher J Romero; Elyse Pine-Twaddell; Daniela I Sima; Ryan S Miller; Ling He; Fredric Wondisford; Sally Radovick
Journal:  Mol Cell Biol       Date:  2012-08-13       Impact factor: 4.272

Review 5.  Class II G protein-coupled receptors and their ligands in neuronal function and protection.

Authors:  Bronwen Martin; Rakel Lopez de Maturana; Randall Brenneman; Tom Walent; Mark P Mattson; Stuart Maudsley
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

Review 6.  Does the pituitary somatotrope play a primary role in regulating GH output in metabolic extremes?

Authors:  Raul M Luque; Manuel D Gahete; Jose Cordoba-Chacon; Gwen V Childs; Rhonda D Kineman
Journal:  Ann N Y Acad Sci       Date:  2011-03       Impact factor: 5.691

7.  Testosterone supplementation in older men restrains insulin-like growth factor's dose-dependent feedback inhibition of pulsatile growth hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Joy N Bailey; Adenborduin Adeniji; John M Miles; Remberto Paulo; Mihaela Cosma; Cacia Soares-Welch
Journal:  J Clin Endocrinol Metab       Date:  2008-11-04       Impact factor: 5.958

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.